
|Articles|January 1, 2005
What's new in PMS?
PMS has been a legitimate diagnosis for several decades, but there are no FDA-approved therapies for it. Off-label use of medications that are FDA-approved for PMDD is common in clinical practice. For patients taking daily SSRIs for anxiety or mood symptoms, premenstrual dose adjustment offers a novel management strategy.
Advertisement
Advertisement
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
HIV screening, PrEP counseling get stronger ACOG recommendation
2
Telehealth expands maternal-fetal medicine access, with Jeffrey Chapa, MD
3
Updated: CMS proposed G-codes for obstetric billing draw concern from ACOG amid coding transition
4
Biomarker testing for preeclampsia with Lisa A. Bukovac, DO, FACOG
5




